Table 1.
ID | Study/year | Study design | Sample size | Sample mean age (years ± SD) | Sex (F/M) |
---|---|---|---|---|---|
A1 | Carhart-Harris et al., 2021 [34] | Randomised | n = 30 treatment group | 43.3 ± 11.7 | 11/19 |
A2 | Davis et al., 2021 [35] | Randomised | n = 13 treatment group | 43.6 ± 13.0 | 9/4 |
A3 | Carhart-Harris et al., 2016 [33] | Open-label trial | n = 12 | 42.7 ± 10.2 | 6/6 |
A4 | Lyons et al., 2018 [37] | Open-label trial | n = 15 treatment group | 45.4 ± 2.9 | 4/11 |
A5 | Carhart-Harris et al., 2017 [23] | Open-label trial | n = 16 | 42.8 ± 10.1 | 4/12 |
A6.a | Goodwin et al., 2022 [36] | Randomised | n = 79 (group A) | 40.2 ± 12.2 | 44/79 |
A6.b | n = 75 (group B) | 40.6 ± 12.8 | 41/75 | ||
A6.c | n = 79 (group C) | 38.7 ± 11.7 | 36/79 |
SD, standard deviation; F, female; M, male.